Shopping Cart
- Remove All
- Your shopping cart is currently empty
Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD (PF-05231023) is a long-acting fibroblast growth factor 21 (FGF21) analog and FGF21-receptor agonist, suitable for development as a potential treatment for T2DM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $46 | In Stock | |
10 mg | $73 | In Stock | |
25 mg | $137 | In Stock | |
50 mg | $223 | In Stock | |
100 mg | $358 | In Stock | |
1 mL x 10 mM (in DMSO) | $59 | In Stock |
Description | Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD (PF-05231023) is a long-acting fibroblast growth factor 21 (FGF21) analog and FGF21-receptor agonist, suitable for development as a potential treatment for T2DM. |
In vitro | PF-05231023 is a analog of long-acting fibroblast growth factor 21 [2]. |
In vivo | Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDsuppresses oxidative-stress-induced inflammation in photoreceptors. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDdecreases the variability of retinal NRF2 levels and displays a trend (non-significant) towards increased NRF2 levels in Akita mice. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDdecreases retinal IL-1β mRNA expression in Akita mice. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDenhances cone-specific arrestin4 expression in Akita mice. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDrestores photoreceptor morphology in Akita mice. Administration of native FGF21 and Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD(3mg/kg or 10mg/kg; subcutaneously twice a week for two weeks) improves glucose tolerance and liver insulin sensitivity in Zucker rats. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD(10 mg/kg; intraperitoneally injected) reduces retinal inflammation in diabetic mice [3][4]. |
Alias | PF-05231023 |
Molecular Weight | 528.55 |
Formula | C26H32N4O8 |
Cas No. | 1037589-69-7 |
Smiles | O=C(CCN1C(=O)C=CC1=O)NCCOCCOCCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1 |
Relative Density. | 1.345 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 125 mg/mL (236.50 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.